Source Pravda.Ru

FDA approves MiddleBrook's amoxicillin drug for strep throat

By Margarita Snegireva. Federal regulators have approved MiddleBrook Pharmaceuticals’ amoxicillin treatment for strep throat, capping eight years of ups and downs that nearly sank the company.

The approval of Moxatag for adolescents and adults, which could shift how one of the more commonly prescribed antibiotics is used, is a win not only for the Germantown company but also for the Maryland biotechnology industry, which has had few products reach the market in recent years despite spending heavily on research.

The U.S. Food and Drug Administration's approval means that patients need to take only one Moxatag pill a day to get rid of the bacteria responsible for strep throat, compared with the traditional antibiotic, penicillin, taken four times a day, both over a period of 10 days.

The Kremlin believes that new possible sanctions against Russia may lead to disastrous consequences, as Washington's actions will come contrary to the generally accepted rules of international trade

New 'bill from hell' against Russia to bring hell to USA

US Deputy Representative to the UN, Jonathan Cohen, stated that Russia should return the Crimea and the Donbass region to Ukraine so that the United States could lift anti-Russian sanctions

US wants Russia to return Crimea, forget Donbass